Accolade and Transcarent announce HSR waiting period expiration for merger
Accolade (ACCD) and Transcarent announced the expiration of the waiting period under the Hart-Scott-Rodino, or HSR, Antitrust Improvements Act ...
CultureMap Austin on MSN4d
Renderings show new convention center coming to Austin for $1.6B
Big changes are coming to the Austin Convention Center, and we now have our first look at what some of them could look like.
First renderings released of what the new Austin Convention Center could look like
The convention center will close in April, with demolition and construction set to begin shortly after. It's expected to ...
Morningstar4d
ACCD Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Accolade, Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Accolade, Inc. (NASDAQ: ACCD) to Transcarent for $7.03 per share in cash is fair to Accolade shareholders.
Transcarent and Accolade Announce Expiration of Hart-Scott Rodino Waiting Period for Pending Merger Transaction
Transcarent is aligned with those who pay for healthcare (self-insured employers, health consumers, and the payors who support them) and creates a measurably better experience, higher-quality health, ...